Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
That's your last free article this week. Create a free account for 4 a week — or go Pro for everything.Go Pro →
Injectables

Allergan Aesthetics Wins FDA Approval for Skinvive by Juvéderm — Neck Indication Expands Filler Portfolio

AbbVie's newest Juvéderm indication targets neck laxity and wrinkles, adding a high-margin treatment to the injectable mix.

Image: Inside MedSpa
1-YEAR MOVE
+15% −13%
ABBV ▲11.6%
1-year price move by ticker
TickerCompany1-year change
ABBVAbbVie (Allergan Aesthetics)+11.6%

Allergan Aesthetics has secured FDA approval for Skinvive by Juvéderm for improvement of neck appearance, marking the first Juvéderm indication specifically cleared for the neck and décolletage. The product is a smooth, cohesive gel formulation designed to address loss of elasticity and fine lines in this notoriously difficult-to-treat zone.

Neck treatment commands premium pricing—often 1.5× to 2× the per-syringe margin of cheek or lip work.

For practice owners, this is a direct revenue play. Neck treatment commands premium pricing—often 1.5× to 2× the per-syringe margin of cheek or lip work—because it requires precision, volume, and repeat sessions. Skinvive's approval gives you a branded, FDA-cleared entry point into a market previously dominated by off-label Juvéderm Ultra XC or Volbella. The indication also sits squarely in the Allē loyalty ecosystem, meaning rebate velocity and per-unit economics will track with AbbVie's broader toxin and filler bundling strategy.

Source: original report ↗

Frequently asked questions

What is Skinvive by Juvéderm used for?

Skinvive by Juvéderm is an FDA-approved filler designed to improve neck appearance by addressing loss of elasticity and fine lines in the neck and décolletage area. It's a smooth, cohesive gel formulation that targets this notoriously difficult-to-treat zone with precision and volume.

Is Skinvive the first Juvéderm approved for the neck?

Yes, Skinvive by Juvéderm is the first Juvéderm indication specifically cleared by the FDA for the neck and décolletage. Previously, practitioners used off-label applications of Juvéderm Ultra XC or Volbella for neck treatment.

How much can you charge for neck filler treatments?

Neck treatments command premium pricing, typically 1.5× to 2× the per-syringe margin of cheek or lip work, due to the precision, volume, and repeat sessions required. This makes neck filler one of the highest-margin injectable treatments available.

Does Skinvive work with the Allē rewards program?

Yes, Skinvive sits within AbbVie's Allē loyalty ecosystem, meaning rebate velocity and per-unit economics track with AbbVie's broader toxin and filler bundling strategy. This integrates neck treatments into existing patient loyalty and bundling programs.

Why is neck filler treatment so profitable for med spas?

Neck filler requires precision application, higher volumes of product, and typically multiple repeat sessions, justifying premium pricing at 1.5–2× standard filler rates. The FDA-cleared indication also eliminates off-label liability and positions it as a branded, high-margin service line.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/abbvie-skinvive-juvederm-fda-neck-approval/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo